Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

27.93 -0.12 (-0.43%)
Official Closing Price Updated: 4:10 PM EDT, Jul 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,646,886
Open 28.05
Bid (Size) 27.94 (4)
Ask (Size) 27.96 (10)
Prev. Close 28.05
Today's Range 27.79 - 28.12
52wk Range 25.20 - 37.80
Shares Outstanding 5,606,688,356
Dividend Yield 5.87%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows
Pfizer's RSV vaccine, Abrysvo, for pregnant women shows no increased risk of pre-term births, according to a study. Researchers found no significant difference in pre-term birth rates between... 
Via Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
Consider buying into these overlooked growth stocks for long-term profits that will help to boost a portfolio and deliver riches. 
Via InvestorPlace

Performance

YTD
-6.05%
-6.05%
1 Month
-2.27%
-2.27%
3 Month
+5.08%
+5.08%
6 Month
-5.58%
-5.58%
1 Year
-21.72%
-21.72%

More News

Read More
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock
Via The Motley Fool
Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?
Via The Motley Fool
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Via Benzinga
Topics ETFs
What the Options Market Tells Us About Pfizer
Via Benzinga
3 Bargain Stocks With the Potential for Mind-Boggling Returns
Via InvestorPlace
MarketBeat Week in Review – 7/1 - 7/5
Via MarketBeat
Topics Economy
Exposures Interest Rates
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July
Via The Motley Fool
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Via Benzinga
3 Stock Giants Analysts Are Bullish On Despite Struggles
Via MarketBeat
3 Dividend Stocks That Are Screaming Buys in July
Via The Motley Fool
Upcoming Stock Spinoffs: Should You Pounce or Pass?
Via InvestorPlace
7 Juicy Dividend Stocks That Have Grown for More Than a Decade
Via InvestorPlace
How To Buy Growth Stocks In An Economy That Isn’t Growing
Via Talk Markets
Topics Economy Stocks
Exposures Economy US Equities
AbbVie Stock: A Perfect Dip for Investors to Buy
Via MarketBeat
Topics ETFs
3 Undervalued Stocks Poised for a Jaw-Dropping Breakout
Via InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Via Benzinga
Exposures COVID-19
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
Via MarketBeat
Exposures Product Safety
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Via MarketBeat
Topics ETFs
Exposures COVID-19
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Via MarketBeat
1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizer's Stock
Via The Motley Fool
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.